incidence and risk factors of oral mucositis in patients with breast cancer who receiving chemotherapy in al-bashir hospital

نویسندگان

ahmed a. al ibraheemi clinical oncology resident doctor, clinical oncology and radiation therapy department, al-bashir hospital, al-ashrafiyah, amman, jordan

shaimaa shamoun oncology nurse specialist, clinical oncology and radiation therapy department, al-bashir hospital, al-ashrafiyah, amman, jordan

چکیده

background: oral mucositis (om) remains the most common side effect of chemotherapy affects negatively on patients' quality of life. subjects and methods : convenience samples of patients who received chemotherapy were followed from first or second cycle of chemotherapy until om occurrence. we reviewed 75 female patients with breast cancer who received chemotherapy with mean age (47.2 sd ± 8.62861). we used who scale to assess the severity of om. demographic and other variables (age, number of cycle before appearance of signs of om, wbc count, neutropenia count, creatinine and bmi) were filled in questionnaire. results: 81.3% of reviewed patients were suffering from om and (52.4%) of them were shown score 2 according to who classification, taxane included chemotherapy protocol was the only significant variable that associated with om occurrence (p=0.009). conclusion: in this study; taxane is the only risk factor that significantly associated with occurrence of om.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Incidence and Risk Factors of Oral Mucositis in Patients with Breast Cancer Who Receiving Chemotherapy in Al-Bashir Hospital

Background: Oral Mucositis (OM) remains the most common side effect of chemotherapy affects negatively on patients' quality of life. Subjects and Methods: Convenience samples of patients who received chemotherapy were followed from first or second cycle of chemotherapy until OM occurrence. We reviewed 75 female patients with breast cancer who received chemotherapy with mean age (47.2 SD ± 8.628...

متن کامل

the study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region

چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...

15 صفحه اول

Prevention and treatment of oral mucositis in patients receiving chemotherapy

Oral mucositis is one of the most common side effects of cancer treatment (chemotherapy and/or radiotherapy). It is an inflammatory process that affects the mucosa of the oral cavity, giving rise to erythematous areas in combination with ulcers that can reach a large size. The true importance of oral mucositis is the complications it causes - fundamentally intense pain associated to the oral ul...

متن کامل

Risk factors for oral mucositis in paediatric oncology patients receiving alkylant chemotherapy

BACKGROUND We describe the risk indicators for oral mucositis (OM) in paediatric oncology patients hospitalised in the Institut Gustave Roussy (Villejuif-Paris) and treated with alkylant chemotherapy with autologous peripheral blood progenitor cells. METHODS The sample was selected using PIGAS software. Three groups of subjects received different chemotherapy regimens: A. Melphalan, B. Busulf...

متن کامل

Effect of cryotherapy on oral mucositis in patients with head and neck cancers receiving radiotherapy

Background: Mucositis is an important adverse effect of cancer treatment. The aim of this study was to investigate the effect of ice cubes on oral mucositis following head and neck radiotherapy. Materials and Methods: A randomized controlled trial was conducted on 40 head and neck cancer patients who underwent radiotherapy. The patients were randomly divided into two experimental and control gr...

متن کامل

Incidence and Risk Factors for Breakthrough Febrile Neutropenia in Cancer Patients Receiving Chemotherapy and Prophylactic Pegfilgrastim

Background: Hematopoietic growth factors (HGFs) reduces the risk of febrile neutropenia (FN) by about 50% in cancer patients receiving chemotherapy. However, breakthrough febrile neutropenia (BTFN) is still a potentially serious complication despite the use of HGFs. Objectives: We aim to investigate the frequency of BTFN and its risk factors in Middle Eastern cancer patients receiving prophylac...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of hematology-oncology and stem cell research

جلد ۱۰، شماره ۴، صفحات ۲۱۷-۲۲۳

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023